Ally Bridge Group
Overview
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Investment Focus
- Focus on innovative life science technologies
- Preference for companies with strong scientific and clinical foundations
- Interest in both private and public equity investments
- Willingness to engage in high-impact transactions
- Alignment with the firm's global healthcare focus
Portfolio Companies
Reach Ally Bridge Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Ally Bridge Group
What sectors does Ally Bridge Group invest in?
Ally Bridge Group invests in Software, Healthcare Services, Medical Devices, Medtech, Biotechnology and Healthcare IT, and is based in New York, Hong Kong. Ally Bridge Group is listed as a vc in the ConnectSafely investor database.
What stage does Ally Bridge Group invest at?
Ally Bridge Group backs companies at Early Stage, Growth, Late Stage, Buyout and Distressed, writing cheques of 10M - 500M.
Which regions does Ally Bridge Group invest in?
Ally Bridge Group invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.
Who are the partners at Ally Bridge Group?
Team members listed for Ally Bridge Group include Frank Yu (Founder, CEO & CIO) and Charles Wong (Chief Operating Officer & Chief Financial Officer).
What companies has Ally Bridge Group invested in?
Ally Bridge Group's portfolio includes Arbor Biotechnologies, VitalConnect, WuXi AppTec, WuXi Biologics, GRAIL, Imperative Care, Venclose Medical and Mavrik Dental Systems.
How do I contact Ally Bridge Group?
Ally Bridge Group's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
